CA2693066A1 - Longitudinally flexible expandable stent - Google Patents

Longitudinally flexible expandable stent Download PDF

Info

Publication number
CA2693066A1
CA2693066A1 CA 2693066 CA2693066A CA2693066A1 CA 2693066 A1 CA2693066 A1 CA 2693066A1 CA 2693066 CA2693066 CA 2693066 CA 2693066 A CA2693066 A CA 2693066A CA 2693066 A1 CA2693066 A1 CA 2693066A1
Authority
CA
Canada
Prior art keywords
band
connector
serpentine
struts
stent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2693066
Other languages
French (fr)
Other versions
CA2693066C (en
Inventor
Brian J. Brown
Michael L. Davis
Michael P. Meyer
Daniel Gregorich
Paul F. Chouinard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2693066A1 publication Critical patent/CA2693066A1/en
Application granted granted Critical
Publication of CA2693066C publication Critical patent/CA2693066C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Abstract

In at least one embodiment, a stent comprises a plurality of serpentine bands and a plurality of connector struts. Each connector strut is connected at one end to a turn of one serpentine band and connected at the other end to a turn of another serpentine band. The turns of a serpentine band comprise connected turns that connect to a connector strut and unconnected turns that do not connect to a connector strut. At least one serpentine band comprises a repeating pattern of three band struts and then five band struts extending between connected turns as the serpentine band is traversed. At least one serpentine band comprises a repeating pattern of three band struts and then one band strut extending between connected turns as the serpentine band is traversed.

Description

LONGITUDINALLY FLEXIBLE EXPANDABLE STENT
BACKGROUND OF THE INVENTION
Field of the Invention In some embodiments this invention relates to implantable medical devices, their manufacture, and methods of use.

Description of the Related Art A stent is a medical device introduced to a body lumen and is well known in the art. Typically, a stent is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called "minimally invasive techniques" in which the stent in a radially reduced configuration, optionally restrained in a radially compressed configuration by a sheath and/or catheter, is delivered by a stent delivery system or "introducer" to the site where it is required. The introducer may enter the body from an access location outside the body, such as through the patient's skin, or by a "cut down"
technique in which the entry blood vessel is exposed by minor surgical means.
Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices, collectively referred to hereinafter as stents, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc. Stents may be used to reinforce body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).
Stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids.
The art referred to and/or described above is not intended to constitute an admission that any patent, publication or other information referred to herein is "prior art" with respect to this invention. In addition, this section should not be construed to mean that a search has been made or that no other pertinent information as defined in 37 C.F.R. 1.56(a) exists.
All US patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.
Without limiting the scope of the invention a brief summary of some of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below.
A brief abstract of the technical disclosure in the specification is provided as well only for the purposes of complying with 37 C.F.R. 1.72. The abstract is not intended to be used for interpreting the scope of the claims.

BRIEF SUMMARY OF THE INVENTION
In at least one embodiment, a stent comprises a plurality of serpentine bands and a plurality of connector columns. Each serpentine band comprises a plurality of alternating straight band struts and turns. Adjacent serpentine bands are connected across a connector column by a plurality of connector struts. Each connector strut is connected at one end to a turn of one serpentine band and connected at the other end to a turn of another serpentine band. The turns of a serpentine band comprise connected turns that connect to a connector strut and unconnected turns that do not connect to a connector strut. At least one serpentine band comprises a repeating pattern of three band struts and then five band struts extending between connected turns as the serpentine band is traversed. At least one serpentine band comprises a repeating pattern of three band struts and then one band strut extending between connected turns as the serpentine band is traversed.
In at least one embodiment, a stent comprises a plurality of serpentine bands and a plurality of connector columns. Each serpentine band comprises a plurality of alternating straight band struts and turns. Adjacent serpentine bands are connected across a connector column by a plurality of connector struts. Each connector strut is connected at one end to a turn of one serpentine band and connected at the other end to a turn of another serpentine band. The turns of a serpentine band comprise connected turns that connect to a connector strut and unconnected turns that do not connect to a connector strut. At least one serpentine band comprises a repeating pattern of three band struts extending between connected turns as the serpentine band is traversed. At least one serpentine band comprises a repeating pattern of three band struts and then one band strut extending between connected turns as the serpentine band is traversed.
These and other embodiments which characterize the invention are pointed out with particularity in the claims annexed hereto and forming a part hereof.
However, for further understanding of the invention, its advantages and objectives obtained by its use, reference should be made to the drawings which form a further part hereof and the accompanying descriptive matter, in which there are illustrated and described further embodiments of the invention.

BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING(S) A detailed description of the invention is hereafter described with specific reference being made to the drawings.
Figure 1 shows a flat view of an embodiment of an unexpanded stent configuration.
Figure 2 shows the pattern of Figure 1 in a tubular, unexpanded stent.
Figure 3 shows an expanded stent of the embodiment shown in Figure 1.
Figure 4 shows a flat view of an alternate unexpanded stent embodiment.
Figure 5 shows a flat pattern for another embodiment of a stent.
Figure 6 shows a three-dimensional isometric view of an embodiment of a stent.
Figure 7 shows a flat pattern depiction of a stent pattern similar to the pattern of Figure 5, in a state of expansion that is greater than that depicted in Figure 5.
Figure 8 shows a flat pattern depiction of a stent pattern similar to the pattern of Figure 7, in a state of expansion that is greater than that depicted in Figure 7.
Figure 9 shows a flat pattern depiction of a stent pattern similar to the pattern of Figure 8, in a state of expansion that is greater than that depicted in Figure 8.
Figure 10 shows a flat pattern depiction of a stent pattern similar to the pattern of Figure 9, in a state of expansion that is greater than that depicted in Figure 9.
The state of expansion shown can be considered a state of overexpansion.
Figure 11 shows a flat pattern for another embodiment of a stent.
Figure 12 shows a flat pattern for another embodiment of a stent.
Figure 13 shows a flat pattern for another embodiment of a stent.
Figure 14 shows a flat pattern for another embodiment of a stent.
DETAILED DESCRIPTION OF THE INVENTION
While this invention may be embodied in many different forms, there are described in detail herein specific embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
The entire disclosure of US Patent Application Attorney Docket No. S63-13089-USO1 is hereby incorporated herein by reference.
The entire disclosures of US Patent Application Nos. 11/604613, 60/85 9460 and 60/844011 are hereby incorporated herein by reference.
For the purposes of this disclosure, like reference numerals in the figures shall refer to like features unless otherwise indicated.
Turning to the Figures, Figure 1 and Figure 2 show a fragmentary flat view of an unexpanded stent configuration and the actual tubular stent (unexpanded), respectively. That is, the stent is shown for clarity in Figure 1 in the flat and may be made from a flat pattern 10 (Figure 1) which is formed into a tubular shape by rolling the pattern so as to bring edges 12 and 14 together (Figure 1). The edges may then joined as by welding or the like to provide a configuration such as that shown in Figure 2.
The configuration can be seen in these Figures to be made up of a plurality of adjacent segments generally indicated at 16, each of which is formed in an undulating flexible pattern of substantially parallel struts 18. Pairs of struts are interconnected at alternating end portions 19a and 19b. As is seen in Figure 1, the interconnecting end portions 19b of one segment are positioned opposite interconnecting end portions 19a of adjacent segments. The end portions as shown are generally elliptical but may be rounded or square or pointed or the like. Any configuration of end portions is acceptable so long as it provides an undulating pattern, as shown.
When the flat form 10 is formed into an unexpanded tube as shown in Figure 2, the segments are cylindrical but the end portions 19 of adjacent segments remain in an opposed position relative to each other.
Interconnecting elements 20 extend from one end portion 19 of one segment 16 to another end portion 19 of another adjacent segment 16 but not to an oppositely positioned end portion 19 of an adjacent segment 16. This results in the interconnecting elements 20 extending in an angular direction between segments around the periphery of the tubular stent.
In some embodiments, there are at least three struts included between the points on each side of a segment 16 at which an interconnecting element 20 contacts an end portion 19.
Interconnecting elements 20 are preferably of the same length but may vary from one segment to the other. Also, the diagonal direction may reverse from one segment to another extending upwardly in one case and downwardly in another, although all connecting elements between any pair of segments are substantially parallel. Figure 1, for example shows them extending downwardly, left to right. Upwardly would extend up left to right in this configuration.
As a result of this angular extension of the interconnecting elements 20 between adjacent segments and loops, upon expansion of the stent as seen in Figure 3, the closest adjacent end portions 19 between segments 16 are displaced from each other and are no longer opposite each other so as to minimize the possibility of binding or overlapping between segments, i.e., pinching.
The number of interconnecting elements 20 may vary depending on circumstances in any particular instance. In some embodiments, a single interconnecting element 20 can span between two adjacent serpentine bands 16. In some embodiments, at least two interconnecting elements 20 can span between two adjacent serpentine bands 16. As shown in Figure 1, in some embodiments, three interconnecting elements 20 can be used.
The alternate design shown in Figure 4 includes longer struts 18a in the two end segments 16a than in the intermediate segments 16. This allows the end segments (16a) to have less compression resistance than the intermediate segments (16), providing a more gradual transition from the native vessel to the support structure of the stent. Otherwise, the configuration is the same as that shown in Figure 1.
In some embodiments, the segments 16 can also be described as serpentine bands. The interconnecting elements 20 can also be described as connector struts. The end portions 19 can also be described as turns. End portions 19a can also be described as proximal peaks. End portions 19b can also be described as distal valleys.
Figure 5 shows a flat pattern for another embodiment of a stent 10 having a proximal end 13, a distal end 15 and a plurality of serpentine bands 16.
Each serpentine band 16 comprises a plurality of band struts 22 and a plurality of turns 28.
The band struts 22 and the turns 28 alternate as the serpentine band 16 is traversed.
Thus, each band strut 22 has a first end 21 connected to one turn 28 and a second end 23 connected to another turn 28. Each turn 28 connects between two band struts 22 that are adjacent to one another in a stent circumferential direction.
In some embodiments, a band strut 22 is straight along its length as shown in Figure 5. In some other embodiments, a band strut 22 can include curvature in one or more directions. A serpentine band 16 can further comprise band struts 22 that are shaped differently from one another. Other examples of possible configurations of band struts 22 are disclosed in US Patent Application Publication No.
2002/0095208 and US Patent Application No. 11/262692, the entire disclosures of which are hereby incorporated herein by reference in their entireties.
The turns 28 of a serpentine band 16 comprise alternating proximal peaks 24 and distal valleys 26. Each proximal peak 24 is generally convex with respect to the proximal end 13 and concave with respect to the distal end 15 of the stent 10.
Each distal valley 26 is generally convex with respect to the distal end 15 and concave with respect to the proximal end 13 of the stent 10. Each turn 28 further comprises an inner side 41 and an outer side 43. Proximal peaks 24 are oriented with the outer side 43 closer to the proximal end 13 of the stent 10 than the inner side 41. Distal valleys 26 are oriented with the outer side 43 closer to the distal end 15 of the stent 10 than the inner side 41.
A stent 10 can have any suitable number of serpentine bands 16. In various embodiments, a serpentine band 16 can have any suitable number of band struts 22 and any suitable number of turns 28.
A serpentine band 16 can span any suitable distance along the length of the stent 10. In some embodiments, a stent 10 can comprise serpentine bands 16 that span different distances. One method for increasing a lengthwise span of a serpentine band 16 is to increase the length of the band struts 22.
In some embodiments, the proximal peaks 24 of a given serpentine band 16 are aligned around a common circumference of the stent 10, and the distal valleys 26 are similarly aligned around another common circumference of the stent 10.
Each circumference can be oriented orthogonal to a longitudinal axis 11 of the stent 10. When turns 28 are aligned around a circumference, an extremity of the outer side 43 of each turn 28 can abut a common reference circumference. In some other embodiments, various peaks 24 can be offset from other peaks 24 within a given serpentine band 16, and various valleys 26 can be offset from other valleys 26 within the band 16.
Each band strut 22 comprises a width, which may be measured in a direction normal to the length of the strut 22. In some embodiments, all struts 22 within a given serpentine band 16 have the same width. In some embodiments, the width of various struts 22 within a serpentine band 16 can be different from one another. In some embodiments, the width of a strut 22 can change along the length of the strut 22. In some embodiments, the width of struts 22 of one serpentine band 16 can be different from the width of struts 22 of another serpentine band 16.
Each turn 28 has a width, which may be measured in a direction normal to the side of the turn 28 (e.g. normal to a tangent line). In some embodiments, the width of a turn 28 can be greater than the width of one or more struts 22 of the stent 10. In some embodiments, the width of a turn 28 can be less than the width of one or more struts 22 of the stent 10. In some embodiments, the width of a turn 28 varies from one end of the turn 28 to the other. For example, a turn 28 can connect to a strut 22 at one end having the same width as the strut 22. The width of the turn 28 increases, and in some embodiments reaches a maximum at a midpoint of the turn 28. The width of the turn 28 then decreases to the width of another strut 22, which may be connected to the second end of the turn 28.
Serpentine bands 16 that are adjacent to one another along the length of the stent 10 are connected by at least one connector strut 20. In some embodiments, a connector strut 20 spans between turns 28 of adjacent serpentine bands 16. For example, a first end 25 of a connector strut 20 can connect to a distal valley 26 of one serpentine band 16, and a second end 27 of the connector strut 20 can connect to a proximal peak 24 of an adjacent serpentine band 16.
Connector struts 20 can connect to any portion of a serpentine band 16.
In some embodiments, a connector strut 20 connects to a turn 28 as shown in Figure 5.
In some embodiments, a connector strut 20 can connect to a band strut 22.
In some embodiments, a connector strut 20 is linear or straight along its length. In some embodiments, a connector strut 20 can include curvature along its length, and can further include multiple portions of curvature, for example a convex portion and a concave portion that may be connected at an inflection point.
Each connector strut 20 comprises a width, which may be measured in a direction normal to the length of the strut 20. In some embodiments, every connector strut 20 has the same width In some other embodiments, a connector strut 20 can have a width that is different from another connector strut 20. In some embodiments, the width of a connector strut 20 can change along the length of the strut 20.
Some further examples of configurations that can be used for connector struts 16 are disclosed in US Patent Nos. 6261319 and 6478816, and US
Published Patent Application No. 20040243216, the entire disclosures of which are hereby incorporated herein by reference.
In some embodiments, connector struts 20 comprise a first type of connector strut 36 and a second type of connector strut 38. A first connector strut 36 extends in a first direction. The first connector strut 36 can be oriented at a first angle to a stent lengthwise axis 11. A second connector strut 38 extends in a second direction that is different than or non-parallel to the first direction. The second connector strut 38 can be oriented at a second angle to a stent lengthwise axis 11. In some embodiments, the first angle and the second angle can have the same magnitude but different orientations. For example, a first connector strut 36 can form a 70 angle with a stent lengthwise axis 11, while a second connector strut 38 can form a negative 70 angle with the stent lengthwise axis 11. In some embodiments, a first angle may comprise a mirror image of a second angle across a line parallel to the stent lengthwise axis 11. In some embodiments, first type of connector strut 36 can have a different shape than second type of connector strut 38.
In some embodiments, an area of the stent 101ocated between two adjacent serpentine bands 16 can be considered a connector column 44. Each connector column 44 comprises a plurality of connector struts 20. In some embodiments, each connector strut 20 in a connector column 44 can be similar to one another. For example, each connector strut 20 in a first connector column 44a can comprise a first type of connector strut 36. Each connector strut 20 in a second connector column 44b can comprise a second type of connector strut 38.
In some embodiments, first connector columns 44a and second connector columns 44b can alternate along the length of the stent 10. Thus, each interior serpentine band 16 can be positioned between a first connector column 44a and a second connector column 44b. Accordingly, connector struts 20 that connect to one side of a serpentine band 16 can comprise first connector struts 36, and connector struts 20 that connect to the other side of the serpentine band 16 can comprise second connector struts 38.
Turns 28 can comprise connected turns 58 or unconnected turns 55 depending upon whether the turn 28 connects to a connector strut 20.
Similarly, proximal peaks 24 can comprise connected proximal peaks 64 or unconnected proximal peaks 74, and distal valleys 26 can comprise connected distal valleys 66 or unconnected distal valleys 76.
A serpentine band 16 can have more unconnected turns 55 than connected turns 58. In some embodiments, a serpentine band 16 has three unconnected turns 55 for each connected turn 58. The 3:1 ratio of unconnected turns 55 to connected turns 58 can also apply to the proximal peaks 24 and to the distal valleys 26.
In some embodiments, as a serpentine band 16 is traversed, there is a repeating pattern of x number of unconnected turns 55 between one connected turn 58 and the next connected turn 58, and then y number of unconnected turns until the next connected turn 58, whereiny is greater than x. For example, referring to Figure 5, as a serpentine band 16a is traversed from a first connected turn 58a to a second connected turn 58b, there are two unconnected turns 55. Thus, x can equal two. As the serpentine band 16a is traversed from the second connected turn 58b to a third connected turn 58c, there are four unconnected turns 55. Thus, y can equal four. The pattern will then repeat, with x=2 unconnected turns 55 between the third connected turn 5 8c and a fourth connected turn 58d, etc. In some embodiments, y is a multiple ofx, for example y=2x.
In some embodiments, starting from a connected turn 58, a serpentine band 16 can comprise three band struts 22 between the connected turn 58 and the next connected turn 58 in a first direction. The serpentine band 16 can further comprise five band struts 22 between the connected turn 58 and the next connected turn 58 in a second direction. For example, referring to Figure 5, a serpentine band 16a includes three band struts 22 between a connected turn 58b and the next connected turn 58a in a first circumferential direction 71. The serpentine band 16a also includes five band struts 22 between the connected turn 58b and the next connected turn 58c in a second circumferential direction 73.
In some embodiments, as a serpentine band 16 is traversed, there can be a repeating pattern of three band struts 22 between one connected turn 58 and the next connected turn 58, and then five band struts 22 until the next connected turn 58. For example, referring to Figure 5, as a serpentine band 16a is traversed from a first connected turn 58a to a second connected turn 58b, there are three band struts 22. As the serpentine band 16a is traversed from the second connected turn 58b to a third connected turn 58c, there are five band struts 22. The pattern will then repeat, with three band struts 22 between the third connected turn 58c and a fourth connected turn 58d, etc.
In some embodiments, an end serpentine band 16e that is located on the proximal end 13 or the distal end 15 of the stent 10 comprises seven unconnected turns 55 between two connected turns 58. The end serpentine band 16e can further comprise eight band struts 22 between two connected turns 58.
In some embodiments, the connector struts 20 of adjacent connector columns 44 are offset from one another in a stent circumferential direction.
For example, one connector strut 20a is offset in a stent circumferential direction from another connector strut 20b located in an adjacent connector column 44. Thus, in some embodiments, a reference line 8 oriented parallel to the stent longitudinal axis 11 that intersects one connector strut 20a will not intersect the other connector strut 20b.
The band struts 22 of a serpentine band 16 can comprise alternating first band struts 22a and second band struts 22b. In some embodiments, each first band strut 22a is parallel to one another as shown in the flat pattern of Figure 5. Each second band strut 22b is parallel to one another and non-parallel to the first band struts 22a.
Serpentine bands 16 can comprise a first type of serpentine band 85 and a second type of serpentine band 89. In some embodiments, each first type of serpentine band 85 is aligned with one another such that similar portions of each band 85 align along the length of the stent 10. Each second type of serpentine band 89 is aligned with one another such that similar portions of each band 89 align along the length of the stent 10. Each first type of serpentine band 85 is offset from each second type of serpentine band 89 such that similar portions of the different types of bands 85, 89 are not aligned along the length of the stent.
In some embodiments, the first type of serpentine band 85 and the second type of serpentine band 89 can alternate along the length of the stent 10.
Thus, serpentine bands 16 that are located adjacent to one another along the length of the stent can be offset from one another in a stent circumferential direction. Every other serpentine band 16 can be aligned with one another in a stent circumferential direction.
For example, a stent 10 can comprise a first serpentine band 16a, a second serpentine 5 band 16b and a third serpentine band 16c along its length. The first and third serpentine bands 16a, 16c comprise a first type of serpentine band 85, and the second serpentine band 16b comprises a second type of serpentine band 89. The first serpentine band 16a is offset from the second serpentine band 16b in a stent circumferential direction. Thus, a reference line 8 extending parallel to the stent longitudinal axis 11 will not intersect 10 similar portions of the first serpentine band 16a and the second serpentine band 16b. As shown, the reference line 8 bisects a proximal peak 24 of the first serpentine band 16a but does not bisect a proximal peak 24 of the second serpentine band 16b. The second serpentine band 16b is similarly offset from the third serpentine band 16c.
The first serpentine band 16a and the third serpentine band 16c are aligned with one another in a stent circumferential direction. Thus, the reference line 8 bisects a proximal peak 24 of both the first serpentine band 16a and the third serpentine band 16c.
One serpentine band 16 of a given type 85, 89 can have connected turns 58 that are aligned with unconnected turns 55 of another serpentine band 16 of the same type 85, 89 along the length of the stent 10. For example, the first serpentine band 16a of Figure 5 includes a connected turn 58c that is longitudinally aligned with an unconnected turn 55a of the third serpentine band 16c.
One serpentine band 16 of a given type 85, 89 can have connected turns 58 that are offset from connected turns 58 of the next adjacent serpentine band 16 of the same type 85, 89 by one proximal peak or one distal valley. For example, the first serpentine band 16a of Figure 5 includes a connected proximal peak 58c that is offset 6 from a connected proximal peak 58e of the third serpentine band 16c by one proximal peak 24. Similarly, the first serpentine band 16a includes a connected distal valley 58d that is offset 7 from a connected distal valley 58f of the third serpentine band 16c by one distal valley 26. Thus, in some embodiments, the connector struts 20 of adjacent similar types of connector columns 44a, 44b are offset from one another in the stent circumferential direction by an amount equal to the spacing 6, 7 between adjacent proximal peaks 24 or between adjacent distal valleys 26.
Referring to Figures 1 and 5, in some embodiments, a stent comprises at least a first serpentine band 101, a second serpentine band 102, a third serpentine band 103 and a fourth serpentine band 104. Each serpentine band 101-104 comprises connected proximal peaks 64, unconnected proximal peaks 74, connected distal valleys 66 and unconnected distal valleys 76. Each serpentine band 101-104 includes at least two unconnected proximal peaks 74 for each connected proximal peak 64, and at least two unconnected distal valleys 76 for each connected distal valley 66.
A first connector strut 121 connects between a first connected distal valley 130, located on the first serpentine band 101, and a connected proximal peak 64 of the second serpentine band 102. A second connector strut 122 connects between the second serpentine band 102 and the third serpentine band 103. A third connector strut 123 connects between a second connected distal valley 132, located on the third serpentine band 103, and a connected proximal peak 64 of the fourth serpentine band 104.
The first connected distal valley 130 is circumferentially aligned with a first unconnected distal valley 116 of the third serpentine band 103. The first unconnected distal valley 116 is directly adjacent in a circumferential direction to the second connected distal valley 132.
Each connected distal valley 66 of the first serpentine band 101 is circumferentially aligned with an unconnected distal valley 76 of the third serpentine band 103. Further, each unconnected distal valley 76 of the third serpentine band 103 that is circumferentially aligned with a connected distal valley 66 of the first serpentine band 101 is offset from a connected distal valley 66 of the third serpentine band 103 in a circumferential direction by one distal valley (e.g. spacing 7 as shown on Figure 5).
The third connector strut 123 is oriented at a non-zero angle to the stent longitudinal axis 11 and thus comprises a circumferential length component l, oriented in a stent circumferential direction. The circumferential length component l, extends from the second connected distal valley 132 in a circumferential direction toward the first unconnected distal valley 116. Thus, in some embodiments, connector struts 20 that connect to connected distal valleys 66 of the third serpentine band 103 extend at an angle to the stent longitudinal axis 11, wherein the angle is oriented in the direction of an adjacent unconnected distal valley 76 (e.g. distal valley 116) that is circumferentially aligned with a connected distal valley 66 (e.g. distal valley 130) of the first serpentine band 101.
The second serpentine band 102 comprises three band struts 22 between the first connector strut 121 and the second connector strut 122. Thus, there are three band struts 22 located between the connected distal valley 66 that connects to the first connector strut 121 and the connected proximal peak 64 that connects to the second connector strut 122.
Each connected distal valley 66 of the second serpentine band 102 is circumferentially aligned with an unconnected distal valley 76 of the fourth serpentine band 104. Further, each unconnected distal valley 76 of the fourth serpentine band 104 that is circumferentially aligned with a connected distal valley 66 of the second serpentine band 102 is offset from a connected distal valley 66 of the fourth serpentine band 104 in a circumferential direction by one distal valley (e.g. spacing 7 as shown on Figure 5).
Figure 6 shows a three-dimensional substantially cylindrical stent 10 according to the flat pattern shown in Figure 5. The stent 10 is shown at a nominal state of expansion and could be further reduced in diameter, for example being crimped onto a delivery catheter, or could be further expanded.
Figure 7 shows an example of a stent 10 in a state of expansion that is greater than that of Figure 5.
Figure 8 shows an example of a stent 10 in a state of expansion that is greater than that of Figure 7.
Figure 9 shows an example of a stent 10 in a state of expansion that is greater than that of Figure 8.
Figure 10 shows an example of a stent 10 in a state of expansion that is greater than that of Figure 9. The amount of expansion depicted can be described as a state of overexpansion. Generally, a stent 10 that is actually used in a bodily vessel will be subject to less expansion than the amount shown in Figure 10. However, the stent 10 pattern shown is capable of providing vessel support even in a substantially overexpanded state.
Figure 11 shows a flat pattern for another embodiment of a stent 10 having a proximal end 13, a distal end 15 and a plurality of serpentine bands 16.
Adjacent serpentine bands 16 are connected across a connector column 44 by a plurality of connector struts 20.
The turns 28 of a serpentine band 16 comprise alternating proximal peaks 24 and distal valleys 26. Each turn 28 can comprise a connected turn 58 or an unconnected turn 55 depending upon whether the turn 28 connects to a connector strut 20. Similarly, proximal peaks 24 can comprise connected proximal peaks 64 or unconnected proximal peaks 74, and distal valleys 26 can comprise connected distal valleys 66 or unconnected distal valleys 76.
In some embodiments, a stent 10 comprises a first portion 46 and a second portion 48. Each portion 46, 48 can comprise a portion of the length of the stent 10. In some embodiments, a connector column 441ocated in the first portion 46 comprises more connector struts 20 than a connector column 441ocated in the second portion 48. In some embodiments, a connector column 441ocated in the first portion 46 comprises twice as many connector struts 20 as a connector column 441ocated in the second portion 48. In some embodiments, each connector column 441ocated in the first portion 46 comprises more connector struts 20 than each connector column 441ocated in the second portion 48.
In some embodiments, the first portion 46 comprises at least two connector columns 44. In some embodiments, the first portion 46 comprises at least three connector columns 44.
In some embodiments, the second portion 48 comprises more connector columns 44 than the first portion 46. In some embodiments, the second portion comprises at least twice as many connector columns 44 as the first portion 46.
In some embodiments, the second portion 48 comprises at least three times as many connector columns 44 as the first portion 46.
In some embodiments, the second portion 48 comprises at least one serpentine band 16 that comprises a repeating pattern of three band struts 22 and then five band struts 22 extending between connected turns 58 as the serpentine band 16 is traversed (3, 5; 3, 5; 3, 5). Thus, referring to Figure 11 and a first serpentine band 16a, starting from a first connected turn 58a, the serpentine band 16a can comprise three band struts 22 between the first connected turn 5 8a and a second connected turn 5 8b, wherein the first and second connected turns 58a, 58b can be considered "adjacent"
connected turns 58 within the serpentine band 16a as the serpentine band 16a is traversed. The serpentine band 16a can further comprise five band struts 22 between the second connected turn 58b and a third connected turn 58c. The pattern can then repeat, with three band struts 22 between the third connected turn 58c and a fourth connected turn 58d, etc.
In some embodiments, the second portion 48 comprises a plurality of serpentine bands 16 that have the repeating pattern of three band struts 22 and then five band struts 22 extending between adjacent connected turns 58. In some embodiments, the second portion 48 can comprise at least four, six or eight or more of such serpentine bands 16.
A serpentine band 16 can similarly comprise a repeating pattern of two unconnected turns 55 and then four unconnected turns 55 extending between connected turns 58 as the serpentine band 16 is traversed (2, 4; 2, 4; 2, 4). Thus, the first serpentine band 16a can comprise two unconnected turns 55 between the first connected turn 58a and the second connected turn 58b as the serpentine band 16a is traversed. The serpentine band 16a can further comprise four unconnected turns 55 between the second connected turn 58b and the third connected turn 58c. The pattern can then repeat, with two unconnected turns 55 between the third connected turn 58c and the fourth connected turn 58d, etc.
In some embodiments, the first portion 46 comprises at least one serpentine band 16 that comprises a repeating pattern of three band struts 22 and then one band strut 22 extending between connected turns 58 as the serpentine band 16 is traversed (3, 1; 3, 1; 3, 1). Thus, a second serpentine band 16b can comprise three band struts 22 between a first connected turn 58e and a second connected turn 58f, and can further comprise one band strut 22 between the second connected turn 58f and a third connected turn 58g. The pattern can then repeat, with three band struts 22 between the third connected turn 58g and the next connected turn 58, etc.
In some embodiments, the first portion 46 comprises a plurality of serpentine bands 16 that have the repeating pattern of three band struts 22 and then one band strut 22 extending between adjacent connected turns 58. In some embodiments, the first portion 46 can comprise at least two or three or more of such serpentine bands 16.
A serpentine band 16 can similarly comprise a repeating pattern of two unconnected turns 55 and then zero unconnected turns 55 extending between connected turns 58 as the serpentine band 16 is traversed (2, 0; 2, 0; 2, 0). Thus, the second serpentine band 16b can comprise two unconnected turns 55 between the first connected turn 58e and the second connected turn 58f as the serpentine band 16b is traversed. The serpentine band 16b can further comprise zero unconnected turns 55 between the second connected turn 58f and the third connected turn 58g. The pattern can then repeat, with two unconnected turns 55 between the third connected turn 58g and the next connected turn 58, etc. This pattern can also be described as a repeating pattern of two connected turns 58 and then two unconnected turns 55 as the serpentine band 16b is traversed.
In some embodiments, a stent 10 further comprises at least one serpentine band 16 that comprises a repeating pattern of four band struts 22, then three band struts 22 and then one band strut 22 extending between connected turns 58 as the serpentine band 16 is traversed (4, 3, 1; 4, 3, 1; 4, 3, 1). Thus, a third serpentine band 16c can comprise four band struts 22 between a first connected turn 58h and a second connected turn 58i, three band struts 22 between the second connected turn 58i and a third connected turn 58j, and one band strut 22 between the third connected turn 58j and a fourth connected turn 58k. The pattern can then repeat, with four band struts between the fourth connected turn 58k and the next connected turn 58, etc. In some embodiments, such a serpentine band 16c can comprise a transitional band between the first portion 46 and the second portion 48 of the stent 10.
A serpentine band 16c can similarly comprise a repeating pattern of three unconnected turns 55, then two unconnected turns 55 and then zero unconnected turns 55 extending between connected turns 58 as the serpentine band 16c is traversed (3, 2, 0;
3, 2, 0; 3, 2, 0). Thus, the third serpentine band 16c can comprise three unconnected turns 55 between the first connected turn 58h and the second connected turn 58i as the serpentine band 16c is traversed. The serpentine band 16c can further comprise two unconnected turns 55 between the second connected turn 58i and the third connected turn 58j, and zero unconnected turns 55 between the third connected turn 58j and the fourth connected turn 58k. The pattern can then repeat, with three unconnected turns 55 between the fourth connected turn 58k and the next connected turn 58, etc.
This pattern can also be described as a repeating pattern of two connected turns 58, three unconnected turns 55, one connected turn 58, and then two unconnected turns 55 as the serpentine band 16c is traversed.
Serpentine bands 16 can comprise a first type of serpentine band 85 and a second type of serpentine band 89. In some embodiments, each first type of serpentine band 85 is aligned with one another such that similar portions of each band 85 align along the length of the stent 10. For example, a proximal peak 24 of a first type of serpentine band 85 can be aligned with a proximal peak 24 of another first type of serpentine band 85 in a direction parallel to the stent longitudinal axis 11.
Each second type of serpentine band 89 is aligned with one another such that similar portions of each band 89 align along the length of the stent 10. For example, a proximal peak 24 of a second type of serpentine band 89 can be aligned with a proximal peak 24 of another second type of serpentine band 89 in a direction parallel to the stent longitudinal axis 11.
Each first type of serpentine band 85 can be offset from each second type of serpentine band 89 such that similar portions of the different types of bands 85, 89 are not aligned along the length of the stent. A proximal peak 24 of a first type of serpentine band 85 can further be aligned with a distal valley 26 of a second type of serpentine band 89 in a direction parallel to the stent longitudinal axis 11.
In some embodiments, the first type of serpentine band 85 and the second type of serpentine band 89 can alternate along the length of the stent 10.
Figure 12 shows a flat pattern for another embodiment of a stent 10. The pattern of Figure 12 has many features similar to the pattern of Figure 11, for example as indicated by like reference characters.
In some embodiments, a stent 10 comprises a first portion 46, a second portion 48 and a third portion 50. Each portion 46, 48, 50 can comprise a portion of the length of the stent 10. In some embodiments, a connector column 441ocated in the first portion 46 or the third portion 50 comprises more connector struts 20 than a connector column 441ocated in the second portion 48. In some embodiments, a connector column 441ocated in the first portion 46 or the third portion 50 comprises twice as many connector struts 20 as a connector column 441ocated in the second portion 48.
In some embodiments, each connector column 441ocated in the first portion 46 or the third portion 50 comprises more connector struts 20 than each connector column 441ocated in the second portion 48. In some embodiments, a connector column 441ocated in the third portion 50 comprises the same number of connector struts 20 as a connector column 44 located in the first portion 46. In some embodiments, the first portion 46 and the third portion 50 can have connector columns 44 with different numbers of connectors.
In some embodiments, the third portion 50 comprises at least two connector columns 44. In some embodiments, the third portion 50 comprises at least three connector columns 44.
In some embodiments, the second portion 48 comprises more connector columns 44 than either the first portion 46 or the third portion 50. In some embodiments, the second portion 48 comprises at least twice as many connector columns 44 than either the first portion 46 or the third portion 50. In some embodiments, the second portion 48 comprises more connector columns 44 than the first portion 46 and the third portion 50 combined.
In some embodiments, the third portion 50 comprises at least one serpentine band 16 that comprises a repeating pattern of three band struts 22 and then one band strut 22 extending between connected turns 58 as the serpentine band 16 is traversed (3, 1; 3, 1; 3, 1).
In some embodiments, the third portion 50 comprises a plurality of serpentine bands 16 that have the repeating pattern of three band struts 22 and then one band strut 22 extending between adjacent connected turns 58. In some embodiments, the third portion 50 can comprise at least two or three or more of such serpentine bands 16.
A serpentine band 16 can similarly comprise a repeating pattern of two unconnected turns 55 and then zero unconnected turns 55 extending between connected turns 58 as the serpentine band 16 is traversed (2, 0; 2, 0; 2, 0).
In some embodiments, a stent 10 further comprises one or more serpentine band(s) 16 that comprise a repeating pattern of four band struts 22, then three band struts 22 and then one band strut 22 extending between connected turns 58 as the serpentine band 16 is traversed (4, 3, 1; 4, 3, 1; 4, 3, 1). For example, Figure 12 shows one such band 16c positioned in a transition between the first region 46 and the second region 48, and another such band 16d positioned in a transition between the second region 48 and the third region 50. Further, bands 16c and 16d can have different orientations. For example, band 16c comprises a second type of band 89 with the repeating pattern extending in one circumferential direction (e.g. downward on Figure 12), while band 16d comprises a first type of band 85 with the repeating pattern extending in a different circumferential direction (e.g. upward on Figure 12).
A serpentine band 16c, 16d can similarly comprise a repeating pattern of three unconnected turns 55, then two unconnected turns 55 and then zero unconnected turns 55 extending between connected turns 58 as the serpentine band 16c is traversed (3, 2, 0; 3, 2, 0; 3, 2, 0).
Figure 13 shows a flat pattern for another embodiment of a stent 10 having a proximal end 13, a distal end 15 and a plurality of serpentine bands 16.
Adjacent serpentine bands 16 are connected across a connector column 44 by a plurality of connector struts 20.
The turns 28 of a serpentine band 16 comprise alternating proximal peaks 24 and distal valleys 26. Each turn 28 can comprise a connected turn 58 or an unconnected turn 55 depending upon whether the turn 28 connects to a connector strut 20. Similarly, proximal peaks 24 can comprise connected proximal peaks 64 or unconnected proximal peaks 74, and distal valleys 26 can comprise connected distal valleys 66 or unconnected distal valleys 76.
In some embodiments, a stent 10 comprises a first portion 46 and a second portion 48. Each portion 46, 48 can comprise a portion of the length of the stent 10. In some embodiments, a connector column 441ocated in the first portion 46 comprises more connector struts 20 than a connector column 441ocated in the second portion 48. In some embodiments, a connector column 441ocated in the first portion 46 comprises at least 1.5 times as many connector struts 20 as a connector column located in the second portion 48. In some embodiments, each connector column located in the first portion 46 comprises more connector struts 20 than each connector column 441ocated in the second portion 48.
In some embodiments, the first portion 46 comprises at least two connector columns 44. In some embodiments, the first portion 46 comprises at least three connector columns 44.
In some embodiments, the second portion 48 comprises more connector columns 44 than the first portion 46. In some embodiments, the second portion comprises at least twice as many connector columns 44 as the first portion 46.
In some embodiments, the second portion 48 comprises at least one serpentine band 16 that comprises a repeating pattern of three band struts 22 extending between connected turns 58 as the serpentine band 16 is traversed (3; 3; 3;
3). Thus, referring to Figure 13 and a first serpentine band 16a, starting from a first connected turn 58a, the serpentine band 16a can comprise three band struts 22 between the first connected turn 58a and a second connected turn 58b, wherein the first and second connected turns 58a, 58b can be considered "adjacent" connected turns 58 within the serpentine band 16a as the serpentine band 16a is traversed. The serpentine band 16a can further comprise three band struts 22 between the second connected turn 58b and a third connected turn 58c, and then three band struts 22 between the third connected turn 58c and the next connected turn 58, etc.
In some embodiments, the second portion 48 comprises a plurality of serpentine bands 16 that have the repeating pattern of three band struts 22 extending between adjacent connected turns 58. In some embodiments, the second portion 48 can comprise at least two, four or six or more of such serpentine bands 16a.
A serpentine band 16 can similarly comprise a repeating pattern of two unconnected turns 55 extending between connected turns 58 as the serpentine band 16 is traversed (2; 2; 2; 2). Thus, the first serpentine band 16a can comprise two unconnected turns 55 between the first connected turn 58a and the second connected turn 58b, then two unconnected turns 55 between the second connected turn 58b and the third connected turn 58c, etc.
In some embodiments, the first portion 46 comprises at least one serpentine band 16 that comprises a repeating pattern of three band struts 22 and then one band strut 22 extending between connected turns 58 as the serpentine band 16 is traversed (3, 1; 3, 1; 3, 1). Thus, a second serpentine band 16b can comprise three band struts 22 between a first connected turn 58e and a second connected turn 58f, and can further comprise one band strut 22 between the second connected turn 58f and a third connected turn 58g. The pattern can then repeat, with three band struts 22 between the third connected turn 58g and the next connected turn 58, etc.
In some embodiments, the first portion 46 comprises a plurality of serpentine bands 16 that have the repeating pattern of three band struts 22 and then one band strut 22 extending between adjacent connected turns 58. In some embodiments, the first portion 46 can comprise at least two or three or more of such serpentine bands 16.
A serpentine band 16 can similarly comprise a repeating pattern of two unconnected turns 55 and then zero unconnected turns 55 extending between connected turns 58 as the serpentine band 16 is traversed (2, 0; 2, 0; 2, 0). Thus, the second serpentine band 16b can comprise two unconnected turns 55 between the first connected turn 58e and the second connected turn 58f as the serpentine band 16b is traversed. The serpentine band 16b can further comprise zero unconnected turns 55 between the second connected turn 58f and the third connected turn 58g. The pattern can then repeat, with two unconnected turns 55 between the third connected turn 58g and the next connected turn 58, etc. This pattern can also be described as a repeating pattern of two connected turns 58 and then two unconnected turns 55 as the serpentine band 16b is traversed.
In some embodiments, a stent 10 further comprises at least one serpentine band 16 that comprises a repeating pattern of three band struts 22, then one band strut 22, then four band struts 22, then one band strut 22 and then three band struts 22 extending between connected turns 58 as the serpentine band 16 is traversed (3, 1, 4, 1, 3; 3, 1, 4, 1, 3). Thus, a third serpentine band 16f can comprise three band struts 22 between a first connected turn 58h and a second connected turn 58i, one band strut 22 between the second connected turn 58i and a third connected turn 58j, four band struts 22 between the third connected turn 58j and a fourth connected turn 58k, one band strut 22 between the fourth connected turn 58k and a fifth connected turn 581, and three band struts 22 between the fifth connected turn 581 and a sixth connected turn 58m.
The pattern can then repeat, with three band struts 22 between the sixth connected turn 58m and the next connected turn 58, etc. In some embodiments, such a serpentine band 16f can comprise a transitional band between the first portion 46 and the second portion 48 of the stent 10.
A serpentine band 16f can similarly comprise a repeating pattern of two unconnected turns 55, then zero unconnected turns 55, then three unconnected turns 55, then zero connected turns 55 and then two unconnected turns 55 extending between connected turns 58 as the serpentine band 16f is traversed (2, 0, 3, 0, 2; 2, 0, 3, 0, 2).
Thus, the third serpentine band 16f can comprise two unconnected turns 55 between the first connected turn 58h and the second connected turn 58i as the serpentine band 16f is traversed. The serpentine band 16f can further comprise zero unconnected turns between the second connected turn 58i and the third connected turn 58j, three unconnected turns 55 between the third connected turn 58j and the fourth connected turn 58k, zero unconnected turns 55 between the fourth connected turn 58k and the fifth connected turn 581, and two unconnected turns 55 between the fifth connected turn 581 and the sixth connected turn 58m. The pattern can then repeat, with two unconnected turns 55 between the sixth connected turn 58m and the next connected turn 58, etc. This pattern can also be described as a repeating pattern of two unconnected turns 55, two connected turns 58, three unconnected turns 55, two connected turns 58, two unconnected turns 55 and then one connected turn 58 as the serpentine band 16f is traversed.
Serpentine bands 16 can comprise a first type of serpentine band 85 and a second type of serpentine band 89. In some embodiments, each first type of serpentine band 85 is aligned with one another such that similar portions of each band 85 align along the length of the stent 10. For example, a proximal peak 24 of a first type of serpentine band 85 can be aligned with a proximal peak 24 of another first type of serpentine band 85 in a direction parallel to the stent longitudinal axis 11.
Each second type of serpentine band 89 is aligned with one another such that similar portions of each band 89 align along the length of the stent 10. For example, a proximal peak 24 of a second type of serpentine band 89 can be aligned with a proximal peak 24 of another second type of serpentine band 89 in a direction parallel to the stent longitudinal axis 11.
Each first type of serpentine band 85 can be offset from each second type of serpentine band 89 such that similar portions of the different types of bands 85, 89 are not aligned along the length of the stent. A proximal peak 24 of a first type of serpentine band 85 can further be aligned with a distal valley 26 of a second type of serpentine band 89 in a direction parallel to the stent longitudinal axis 11.
In some embodiments, the first type of serpentine band 85 and the second type of serpentine band 89 can alternate along the length of the stent 10.
Figure 14 shows a flat pattern for another embodiment of a stent 10. The pattern of Figure 14 has many features similar to the pattern of Figure 13, for example as indicated by like reference characters.
In some embodiments, a stent 10 comprises a first portion 46, a second portion 48 and a third portion 50. Each portion 46, 48, 50 can comprise a portion of the length of the stent 10. In some embodiments, a connector column 441ocated in the first portion 46 or the third portion 50 comprises more connector struts 20 than a connector column 441ocated in the second portion 48. In some embodiments, a connector column 441ocated in the first portion 46 or the third portion 50 comprises twice as many connector struts 20 as a connector column 441ocated in the second portion 48.
In some embodiments, each connector column 441ocated in the first portion 46 or the third portion 50 comprises more connector struts 20 than each connector column 441ocated in the second portion 48. In some embodiments, a connector column 441ocated in the third portion 50 comprises the same number of connector struts 20 as a connector column 44 located in the first portion 46. In some embodiments, the first portion 46 and the third portion 50 can have connector columns 44 with different numbers of connectors.
In some embodiments, the third portion 50 comprises at least two connector columns 44. In some embodiments, the third portion 50 comprises at least three connector columns 44.
In some embodiments, the second portion 48 comprises more connector columns 44 than either the first portion 46 or the third portion 50. In some embodiments, the second portion 48 comprises at least twice as many connector columns 44 than either the first portion 46 or the third portion 50. In some embodiments, the second portion 48 comprises more connector columns 44 than the first portion 46 and the third portion 50 combined.
In some embodiments, the third portion 50 comprises at least one serpentine band 16 that comprises a repeating pattern of three band struts 22 and then one band strut 22 extending between connected turns 58 as the serpentine band 16 is traversed (3, 1; 3, 1; 3, 1).
In some embodiments, the third portion 50 comprises a plurality of serpentine bands 16 that have the repeating pattern of three band struts 22 and then one band strut 22 extending between adjacent connected turns 58. In some embodiments, the third portion 50 can comprise at least two or three or more of such serpentine bands 16.
A serpentine band 16 can similarly comprise a repeating pattern of two unconnected turns 55 and then zero unconnected turns 55 extending between connected turns 58 as the serpentine band 16 is traversed (2, 0; 2, 0; 2, 0).
In some embodiments, a stent 10 further comprises one or more serpentine band(s) 16 that comprise a repeating pattern of three band struts 22, then one band strut 22, then four band struts 22, then one band strut 22 and then three band struts 22 extending between connected turns 58 as the serpentine band 16 is traversed (3, 1, 4, 1, 3; 3, 1, 4, 1, 3). For example, Figure 14 shows one such band 16f positioned in a transition between the first region 46 and the second region 48, and another such band 16g positioned in a transition between the second region 48 and the third region 50.
Further, bands 16f and 16g can have different orientations. For example, band 16f comprises a second type of band 89, while band 16g comprises a first type of band 85.
A serpentine band 16f, 16g can similarly comprise a repeating pattern of two unconnected turns 55, then zero unconnected turns 55, then three unconnected turns 55, then zero connected turns 55 and then two unconnected turns 55 extending between connected turns 58 as the serpentine band 16f, 16g is traversed (2, 0, 3, 0, 2; 2, 0, 3, 0, 2).
The inventive stents may be made from any suitable biocompatible materials including one or more polymers, one or more metals or combinations of polymer(s) and metal(s). Examples of suitable materials include biodegradable materials that are also biocompatible. In some embodiments, a stent can have one or more components constructed from one or more metals, polymers or combinations thereof that are corrodible so as to dissolve, dissociate or otherwise break down in the body without ill effect. Examples of such materials have been referred to as being degradable, biodegradable, biologically degradable, erodable, bioabsorbable, bioresorbable, and the like. Biodegradable material will generally undergo breakdown or decomposition into harmless compounds as part of a normal biological process. Suitable biodegradable materials include polylactic acid, polyglycolic acid (PGA), collagen or other connective proteins or natural materials, polycaprolactone, hylauric acid, adhesive proteins, co-polymers of these materials as well as composites and combinations thereof and combinations of other biodegradable polymers. Other polymers that may be used include polyester and polycarbonate copolymers. Examples of suitable metals include, but are not limited to, stainless steel, titanium, tantalum, platinum, tungsten, gold and alloys of any of the above-mentioned metals. Examples of suitable alloys include platinum-iridium alloys, cobalt-chromium alloys including Elgiloy and Phynox, MP35N alloy and nickel-titanium alloys, for example, Nitinol. Some further examples of biodegradable alloys, such as magnesium alloys and zinc alloys, are disclosed in US 6,854,172 and US
2006/0052864, the entire contents of which are hereby incorporated herein by reference.
The inventive stents may be made of shape memory materials such as superelastic Nitinol or spring steel, or may be made of materials which are plastically deformable. In the case of shape memory materials, the stent may be provided with a memorized shape and then deformed to a reduced diameter shape. The stent may restore itself to its memorized shape upon being heated to a transition temperature and having any restraints removed therefrom.
The inventive stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids. Any other suitable technique which is known in the art or which is subsequently developed may also be used to manufacture the inventive stents disclosed herein.
In some embodiments the stent, the delivery system or other portion of the assembly may include one or more areas, bands, coatings, members, etc.
that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc. In some embodiments at least a portion of the stent and/or adjacent assembly is at least partially radiopaque.
In some embodiments the at least a portion of the stent is configured to include one or more mechanisms for the delivery of a therapeutic agent. Often the agent will be in the form of a coating or other layer (or layers) of material placed on a surface region of the stent, which is adapted to be released at the site of the stent's implantation or areas adjacent thereto.
A therapeutic agent may be a drug or other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc. Some examples of suitable non-genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc. Some other examples of therapeutic agents include everolimus and sirolimus, their analogs and conjugates. Where an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to:
DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc. Where a therapeutic agent includes cellular material, the cellular material may include but is not limited to: cells of human origin and/or non-human origin as well as their respective components and/or derivatives thereof. Where the therapeutic agent includes a polymer agent, the polymer agent may be a polystyrene-polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.
The above disclosure is intended to be illustrative and not exhaustive.
This description will suggest many variations and alternatives to one of ordinary skill in this art. The various elements shown in the individual figures and described above may be combined or modified for combination as desired. All these alternatives and variations are intended to be included within the scope of the claims where the term "comprising"
means "including, but not limited to".
Further, the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims.
For instance, for purposes of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.
This completes the description of the invention. Those skilled in the art may recognize other equivalents to the specific embodiment described herein which equivalents are intended to be encompassed by the claims attached hereto.

Claims (20)

1. A stent comprising a plurality of serpentine bands and a plurality of connector columns, each serpentine band comprising a plurality of alternating straight band struts and turns, adjacent serpentine bands connected across a connector column by a plurality of connector struts, each connector strut connected at one end to a turn of one serpentine band and connected at the other end to a turn of another serpentine band, the turns of a serpentine band comprising connected turns that connect to a connector strut and unconnected turns that do not connect to a connector strut;
at least one serpentine band comprising a repeating pattern of three band struts and then five band struts extending between connected turns as the serpentine band is traversed; and at least one serpentine band comprising a repeating pattern of three band struts and then one band strut extending between connected turns as the serpentine band is traversed.
2. The stent of claim 1, wherein a serpentine band comprises a repeating pattern of four band struts, then three band struts and then one band strut extending between connected turns as the serpentine band is traversed.
3. The stent of claim 1, wherein a plurality of the serpentine bands comprise a repeating pattern of three band struts and then five band struts extending between connected turns.
4. The stent of claim 1, wherein a plurality of the serpentine bands comprise a repeating pattern of three band struts and then one band strut extending between connected turns.
5. The stent of claim 1, comprising a first length portion and a second length portion, wherein a connector column in the first length portion comprises more connector struts than a connector column in the second length portion.
6. The stent of claim 5, wherein each connector column in the first length portion comprises more connector struts than each connector column in the second length portion.
7. The stent of claim 6, wherein the first length portion comprises at least two connector columns.
8. The stent of claim 1, wherein the connector columns comprise first connector columns and second connector columns, connector struts of the first connector columns being parallel to one another, connector struts of the second connector columns being nonparallel to the connector struts of the first connector colunms.
9. The stent of claim 8, wherein first connector columns and second connector columns alternate along the length of the stent.
10. The stent of claim 1, wherein the turns of each serpentine band comprise alternating proximal peaks and distal valleys, the proximal peaks of one serpentine band aligned in a stent axial direction with the distal valleys of an adjacent serpentine band.
11. A stent comprising a plurality of serpentine bands and a plurality of connector columns, each serpentine band comprising a plurality of alternating straight band struts and turns, adjacent serpentine bands connected across a connector column by a plurality of connector struts, each connector strut connected at one end to a turn of one serpentine band and connected at the other end to a turn of another serpentine band, the turns of a serpentine band comprising connected turns that connect to a connector strut and unconnected turns that do not connect to a connector strut;
at least one serpentine band comprising a repeating pattern of three band struts extending between connected turns as the serpentine band is traversed; and at least one serpentine band comprising a repeating pattern of three band struts and then one band strut extending between connected turns as the serpentine band is traversed.
12. The stent of claim 11, wherein a serpentine band comprises a repeating pattern of three band struts, one band strut, four band struts, one band strut, and then three band struts extending between connected turns as the serpentine band is traversed.
13. The stent of claim 11, wherein a plurality of the serpentine bands comprise a repeating pattern of three band struts extending between connected turns.
14. The stent of claim 11, wherein a plurality of the serpentine bands comprise a repeating pattern of three band struts and then one band strut extending between connected turns.
15. The stent of claim 11, comprising a first length portion and a second length portion, wherein a connector column in the first length portion comprises more connector struts than a connector column in the second length portion.
16. The stent of claim 15, wherein each connector column in the first length portion comprises more connector struts than each connector column in the second length portion.
17. The stent of claim 16, wherein the first length portion comprises at least two connector columns.
18. The stent of claim 11, wherein the connector columns comprise first connector columns and second connector columns, connector struts of the first connector columns being parallel to one another, connector struts of the second connector columns being nonparallel to the connector struts of the first connector columns.
19. The stent of claim 18, wherein first connector columns and second connector columns alternate along the length of the stent.
20. The stent of claim 11, wherein the turns of each serpentine band comprise alternating proximal peaks and distal valleys, the proximal peaks of one serpentine band aligned in a stent axial direction with the distal valleys of an adjacent serpentine band.
CA2693066A 2007-07-20 2008-07-07 Longitudinally flexible expandable stent Expired - Fee Related CA2693066C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/781,031 US7988720B2 (en) 2006-09-12 2007-07-20 Longitudinally flexible expandable stent
US11/781,031 2007-07-20
PCT/US2008/069345 WO2009014888A1 (en) 2007-07-20 2008-07-07 Longitudinally flexible expandable stent

Publications (2)

Publication Number Publication Date
CA2693066A1 true CA2693066A1 (en) 2009-01-29
CA2693066C CA2693066C (en) 2015-04-28

Family

ID=39193640

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2693066A Expired - Fee Related CA2693066C (en) 2007-07-20 2008-07-07 Longitudinally flexible expandable stent

Country Status (6)

Country Link
US (2) US7988720B2 (en)
EP (1) EP2173284A1 (en)
JP (1) JP2010534088A (en)
CN (1) CN101969890A (en)
CA (1) CA2693066C (en)
WO (1) WO2009014888A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
EP0884029B1 (en) 1997-06-13 2004-12-22 Gary J. Becker Expandable intraluminal endoprosthesis
US7988723B2 (en) * 2007-08-02 2011-08-02 Flexible Stenting Solutions, Inc. Flexible stent
DE102008048416A1 (en) * 2008-08-05 2010-02-11 Acandis Gmbh & Co. Kg Medical device and method for manufacturing such a device
EP2485688B1 (en) * 2009-10-06 2019-09-04 Sahajanand Medical Technologies Private Limited Bioresorbable vascular implant having homogenously distributed stresses under a radial load
AU2010313389A1 (en) * 2009-10-30 2012-05-31 Cordis Corporation Intraluminal device with improved flexibility and durability
WO2011123203A1 (en) * 2010-03-29 2011-10-06 Boston Scientific Scimed, Inc. Flexible stent design
KR101244159B1 (en) 2011-02-23 2013-03-25 주식회사 엘티에스 Stent
US20130123905A1 (en) * 2011-11-15 2013-05-16 Abbott Cardiovascular Systems Inc. Offset peak-to-peak stent pattern
ES2694006T3 (en) * 2013-06-20 2018-12-17 Biosensors International Group Ltd. A vascular stent with a mixed configuration of connectors
CN105451691B (en) 2013-06-21 2018-07-17 波士顿科学国际有限公司 Holder with deflection connector
EP3188698A1 (en) * 2014-09-04 2017-07-12 Boston Scientific Scimed, Inc. Bioerodible polymeric stent scaffolding pattern
CN109984864B (en) * 2017-12-29 2020-07-17 先健科技(深圳)有限公司 Stent for branch vessels

Family Cites Families (300)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2836181A (en) 1955-01-17 1958-05-27 Chemstrand Corp Flexible nylon tube and method for preparing same
US3105492A (en) 1958-10-01 1963-10-01 Us Catheter & Instr Corp Synthetic blood vessel grafts
US3272204A (en) 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
GB1104680A (en) 1965-10-18 1968-02-28 Univ Birmingham Artificial artery
AT261800B (en) 1966-08-22 1968-05-10 Braun Internat Gmbh B Process for the manufacture of tubular, smooth or threaded tissue-blood vessel prostheses
US3509883A (en) 1967-11-29 1970-05-05 Gen Electric Expanding cannula
US3526228A (en) 1969-03-24 1970-09-01 Ethicon Inc Collagen lamina dural prosthesis
US3635215A (en) 1969-08-14 1972-01-18 Gam Rad Medical removal hook
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3771526A (en) 1972-02-07 1973-11-13 P Rudie Anastomosis clamp
US3868956A (en) 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
SE397769B (en) 1974-11-04 1977-11-21 Gambro Ab INITIATIVE ELEMENTS FOR USE IN VEHICLE SURGERY AND METHODS OF PRODUCING SUCCESSFUL
GB1591793A (en) 1976-10-25 1981-06-24 Welding Inst Laser welding
US4078167A (en) 1977-02-09 1978-03-07 United Technologies Corporation Welding shield and plasma suppressor apparatus
US4140126A (en) 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4141364A (en) 1977-03-18 1979-02-27 Jorge Schultze Expandable endotracheal or urethral tube
US4130904A (en) 1977-06-06 1978-12-26 Thermo Electron Corporation Prosthetic blood conduit
US4164045A (en) 1977-08-03 1979-08-14 Carbomedics, Inc. Artificial vascular and patch grafts
AU516741B2 (en) 1978-05-23 1981-06-18 Bio Nova Neo Technics Pty. Ltd. Vascular prostheses
WO1980000007A1 (en) 1978-06-02 1980-01-10 A Rockey Medical sleeve
US4214587A (en) 1979-02-12 1980-07-29 Sakura Chester Y Jr Anastomosis device and method
US4300244A (en) 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
JPS6028434Y2 (en) 1980-06-16 1985-08-28 建部 容保 Artificial blood vessel
US4441215A (en) 1980-11-17 1984-04-10 Kaster Robert L Vascular graft
AT392733B (en) 1981-09-16 1991-05-27 Medinvent Sa DEVICE FOR TREATING BLOOD VESSELS OR THE LIKE.
US4425908A (en) 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4470407A (en) 1982-03-11 1984-09-11 Laserscope, Inc. Endoscopic device
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4597389A (en) 1982-09-30 1986-07-01 Ibrahim Adel A Device for removing objects from tubular body passages
US4512338A (en) 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4503569A (en) 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4647416A (en) 1983-08-03 1987-03-03 Shiley Incorporated Method of preparing a vascular graft prosthesis
US4550447A (en) 1983-08-03 1985-11-05 Shiley Incorporated Vascular graft prosthesis
US4665906A (en) 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4560374A (en) 1983-10-17 1985-12-24 Hammerslag Julius G Method for repairing stenotic vessels
US4535770A (en) 1983-11-02 1985-08-20 Lemole Gerald M Cardiovascular tourniquet
US4787899A (en) 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US5104399A (en) 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US4655776A (en) 1984-01-12 1987-04-07 Oto Enterprises, Inc. Prostheses for ossicular reconstruction
US4842575A (en) 1984-01-30 1989-06-27 Meadox Medicals, Inc. Method for forming impregnated synthetic vascular grafts
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
CA1264674A (en) 1984-10-17 1990-01-23 Paul Ducheyne Porous flexible metal fiber material for surgical implantation
SE450809B (en) 1985-04-10 1987-08-03 Medinvent Sa PLANT TOPIC PROVIDED FOR MANUFACTURING A SPIRAL SPRING SUITABLE FOR TRANSLUMINAL IMPLANTATION AND MANUFACTURED SPIRAL SPRINGS
SE447061B (en) 1985-06-10 1986-10-27 Medinvent Sa INFO DEVICE, SPEC FOR IMPLEMENTATION IN A LIVE ORGANISM
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
DE3640745A1 (en) 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Catheter for producing or extending connections to or between body cavities
US4681110A (en) 1985-12-02 1987-07-21 Wiktor Dominik M Catheter arrangement having a blood vessel liner, and method of using it
US4851009A (en) 1985-12-16 1989-07-25 Corvita Corporation Crack prevention of implanted prostheses
US4665918A (en) 1986-01-06 1987-05-19 Garza Gilbert A Prosthesis system and method
US4649922A (en) 1986-01-23 1987-03-17 Wiktor Donimik M Catheter arrangement having a variable diameter tip and spring prosthesis
EP0556940A1 (en) 1986-02-24 1993-08-25 Robert E. Fischell Intravascular stent
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4740207A (en) 1986-09-10 1988-04-26 Kreamer Jeffry W Intralumenal graft
SE455834B (en) 1986-10-31 1988-08-15 Medinvent Sa DEVICE FOR TRANSLUMINAL IMPLANTATION OF A PRINCIPLE RODFORMALLY RADIALLY EXPANDABLE PROSTHESIS
US4762128A (en) 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4795465A (en) 1987-05-14 1989-01-03 Hood Laboratories Tracheobronchial stent
US4872874A (en) 1987-05-29 1989-10-10 Taheri Syde A Method and apparatus for transarterial aortic graft insertion and implantation
US4769029A (en) 1987-06-19 1988-09-06 Patel Jayendrakumar I Prosthetic graft for arterial system repair
US5059211A (en) 1987-06-25 1991-10-22 Duke University Absorbable vascular stent
US4795458A (en) 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
JPS6446477A (en) 1987-08-13 1989-02-20 Terumo Corp Catheter
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5133732A (en) 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US4820298A (en) 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
JP2561853B2 (en) 1988-01-28 1996-12-11 株式会社ジェイ・エム・エス Shaped memory molded article and method of using the same
US4877030A (en) 1988-02-02 1989-10-31 Andreas Beck Device for the widening of blood vessels
US4830003A (en) 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US5019090A (en) 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5226913A (en) 1988-09-01 1993-07-13 Corvita Corporation Method of making a radially expandable prosthesis
US5092877A (en) 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US5108415A (en) 1988-10-04 1992-04-28 Cordis Corporation Balloons for medical devices and fabrication thereof
CA1322628C (en) 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US4913141A (en) 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4950227A (en) 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US5091205A (en) 1989-01-17 1992-02-25 Union Carbide Chemicals & Plastics Technology Corporation Hydrophilic lubricious coatings
US5147400A (en) 1989-05-10 1992-09-15 United States Surgical Corporation Connective tissue prosthesis
US4994071A (en) 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5037392A (en) 1989-06-06 1991-08-06 Cordis Corporation Stent-implanting balloon assembly
US5015253A (en) 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
IE73670B1 (en) 1989-10-02 1997-07-02 Medtronic Inc Articulated stent
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5147385A (en) 1989-11-01 1992-09-15 Schneider (Europe) A.G. Stent and catheter for the introduction of the stent
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5071407A (en) 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5158548A (en) 1990-04-25 1992-10-27 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5122154A (en) 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
US5139480A (en) 1990-08-22 1992-08-18 Biotech Laboratories, Inc. Necking stents
US5108417A (en) 1990-09-14 1992-04-28 Interface Biomedical Laboratories Corp. Anti-turbulent, anti-thrombogenic intravascular stent
US5344425A (en) 1990-09-14 1994-09-06 Interface Biomedical Laboratories, Corp. Intravascular stent and method for conditioning the surfaces thereof
US5163952A (en) 1990-09-14 1992-11-17 Michael Froix Expandable polymeric stent with memory and delivery apparatus and method
US5148265A (en) 1990-09-24 1992-09-15 Ist Associates, Inc. Semiconductor chip assemblies with fan-in leads
DE9116881U1 (en) 1990-10-09 1994-07-07 Cook Inc Percutaneous stent
US5217483A (en) 1990-11-28 1993-06-08 Numed, Inc. Intravascular radially expandable stent
US5356423A (en) 1991-01-04 1994-10-18 American Medical Systems, Inc. Resectable self-expanding stent
US5135536A (en) 1991-02-05 1992-08-04 Cordis Corporation Endovascular stent and method
US5197978B1 (en) 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5304200A (en) 1991-05-29 1994-04-19 Cordis Corporation Welded radially expandable endoprosthesis and the like
US5527354A (en) 1991-06-28 1996-06-18 Cook Incorporated Stent formed of half-round wire
US5314472A (en) 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
US5354309A (en) 1991-10-11 1994-10-11 Angiomed Ag Apparatus for widening a stenosis in a body cavity
CA2380683C (en) 1991-10-28 2006-08-08 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
FR2683449A1 (en) 1991-11-08 1993-05-14 Cardon Alain ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION.
US5507767A (en) 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5405377A (en) 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US5683448A (en) 1992-02-21 1997-11-04 Boston Scientific Technology, Inc. Intraluminal stent and graft
US5282823A (en) 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5599352A (en) 1992-03-19 1997-02-04 Medtronic, Inc. Method of making a drug eluting stent
US5370683A (en) 1992-03-25 1994-12-06 Cook Incorporated Vascular stent
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5354308A (en) 1992-05-01 1994-10-11 Beth Israel Hospital Association Metal wire stent
GR1002388B (en) 1993-01-06 1996-07-03 Ethicon Inc. Stent.
DE4303181A1 (en) 1993-02-04 1994-08-11 Angiomed Ag Implantable catheter
JPH08507715A (en) 1993-03-18 1996-08-20 シーダーズ サイナイ メディカル センター Drug-inducing and releasable polymeric coatings for bioartificial components
US5464650A (en) 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US5824048A (en) 1993-04-26 1998-10-20 Medtronic, Inc. Method for delivering a therapeutic substance to a body lumen
US5735892A (en) 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5913897A (en) 1993-09-16 1999-06-22 Cordis Corporation Endoprosthesis having multiple bridging junctions and procedure
US5389106A (en) 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
EP0657147B1 (en) 1993-11-04 1999-08-04 C.R. Bard, Inc. Non-migrating vascular prosthesis
US6051020A (en) 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5643312A (en) 1994-02-25 1997-07-01 Fischell Robert Stent having a multiplicity of closed circular structures
ATE166782T1 (en) 1994-02-25 1998-06-15 Fischell Robert STENT WITH A MULTIPLE CLOSED CIRCULAR STRUCTURES
US5549663A (en) 1994-03-09 1996-08-27 Cordis Corporation Endoprosthesis having graft member and exposed welded end junctions, method and procedure
US6464722B2 (en) 1994-03-17 2002-10-15 Medinol, Ltd. Flexible expandable stent
US5733303A (en) 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US6461381B2 (en) 1994-03-17 2002-10-08 Medinol, Ltd. Flexible expandable stent
US5843120A (en) 1994-03-17 1998-12-01 Medinol Ltd. Flexible-expandable stent
US6165210A (en) 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
EP0679372B1 (en) 1994-04-25 1999-07-28 Advanced Cardiovascular Systems, Inc. Radiopaque stent markers
US5554181A (en) 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
EP0759730B1 (en) 1994-05-19 1999-02-10 Scimed Life Systems, Inc. Improved tissue supporting devices
DE4418336A1 (en) 1994-05-26 1995-11-30 Angiomed Ag Stent for widening and holding open receptacles
US6013854A (en) 1994-06-17 2000-01-11 Terumo Kabushiki Kaisha Indwelling stent and the method for manufacturing the same
US5591230A (en) 1994-09-07 1997-01-07 Global Therapeutics, Inc. Radially expandable stent
US5545210A (en) 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5836964A (en) 1996-10-30 1998-11-17 Medinol Ltd. Stent fabrication method
US5800521A (en) 1994-11-09 1998-09-01 Endotex Interventional Systems, Inc. Prosthetic graft and method for aneurysm repair
CA2163824C (en) 1994-11-28 2000-06-20 Richard J. Saunders Method and apparatus for direct laser cutting of metal stents
FR2727854A1 (en) 1994-12-09 1996-06-14 Jean Claude Sgro AUTOEXPANSIBLE ENDOPROTHESIS
US5630829A (en) 1994-12-09 1997-05-20 Intervascular, Inc. High hoop strength intraluminal stent
IT1273855B (en) 1994-12-16 1997-07-11 Xtrode Srl PROSTHESIS FOR VENOUS CAVITY
JP3311899B2 (en) 1995-01-20 2002-08-05 松下電器産業株式会社 Circuit board and method of manufacturing the same
US5755770A (en) 1995-01-31 1998-05-26 Boston Scientific Corporatiion Endovascular aortic graft
CA2213403C (en) 1995-02-22 2007-01-16 Menlo Care, Inc. Covered expanding mesh stent
CA2186029C (en) 1995-03-01 2003-04-08 Brian J. Brown Improved longitudinally flexible expandable stent
US6818014B2 (en) 1995-03-01 2004-11-16 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
US6981986B1 (en) 1995-03-01 2006-01-03 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US7204848B1 (en) * 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US6896696B2 (en) 1998-11-20 2005-05-24 Scimed Life Systems, Inc. Flexible and expandable stent
US6579314B1 (en) 1995-03-10 2003-06-17 C.R. Bard, Inc. Covered stent with encapsulated ends
US6451047B2 (en) 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
US6124523A (en) 1995-03-10 2000-09-26 Impra, Inc. Encapsulated stent
US5591197A (en) 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
EP0734698B9 (en) 1995-04-01 2006-07-05 Variomed AG Stent for transluminal implantation into hollow organs
BE1009278A3 (en) 1995-04-12 1997-01-07 Corvita Europ Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as.
US5613981A (en) 1995-04-21 1997-03-25 Medtronic, Inc. Bidirectional dual sinusoidal helix stent
SE514193C2 (en) 1995-05-18 2001-01-22 Teknikbolaget Ab Fire extinguishers for enclosed spaces
US5593442A (en) 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US6287336B1 (en) 1995-10-16 2001-09-11 Medtronic, Inc. Variable flexibility stent
WO1997014375A1 (en) 1995-10-20 1997-04-24 Bandula Wijay Vascular stent
US5824040A (en) 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US5843158A (en) 1996-01-05 1998-12-01 Medtronic, Inc. Limited expansion endoluminal prostheses and methods for their use
US5800512A (en) 1996-01-22 1998-09-01 Meadox Medicals, Inc. PTFE vascular graft
US5895406A (en) 1996-01-26 1999-04-20 Cordis Corporation Axially flexible stent
US5938682A (en) 1996-01-26 1999-08-17 Cordis Corporation Axially flexible stent
US6017363A (en) 1997-09-22 2000-01-25 Cordis Corporation Bifurcated axially flexible stent
US5980553A (en) 1996-12-20 1999-11-09 Cordis Corporation Axially flexible stent
US5843117A (en) 1996-02-14 1998-12-01 Inflow Dynamics Inc. Implantable vascular and endoluminal stents and process of fabricating the same
CA2192520A1 (en) 1996-03-05 1997-09-05 Ian M. Penn Expandable stent and method for delivery of same
NZ331269A (en) 1996-04-10 2000-01-28 Advanced Cardiovascular System Expandable stent, its structural strength varying along its length
US6039756A (en) 1996-04-26 2000-03-21 Jang; G. David Intravascular stent
JP4636634B2 (en) 1996-04-26 2011-02-23 ボストン サイエンティフィック サイムド,インコーポレイテッド Intravascular stent
US6235053B1 (en) 1998-02-02 2001-05-22 G. David Jang Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US6241760B1 (en) 1996-04-26 2001-06-05 G. David Jang Intravascular stent
US5954743A (en) 1996-04-26 1999-09-21 Jang; G. David Intravascular stent
US5922021A (en) 1996-04-26 1999-07-13 Jang; G. David Intravascular stent
US5951586A (en) 1996-05-15 1999-09-14 Medtronic, Inc. Intraluminal stent
US5800514A (en) 1996-05-24 1998-09-01 Meadox Medicals, Inc. Shaped woven tubular soft-tissue prostheses and methods of manufacturing
US5697971A (en) 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5928279A (en) 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
FR2750853B1 (en) 1996-07-10 1998-12-18 Braun Celsa Sa MEDICAL PROSTHESIS, IN PARTICULAR FOR ANEVRISMS, WITH PERFECTIONED CONNECTION BETWEEN ITS SHEATH AND ITS STRUCTURE
US5755781A (en) 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US6123712A (en) 1996-08-23 2000-09-26 Scimed Life Systems, Inc. Balloon catheter with stent securement means
US5776183A (en) 1996-08-23 1998-07-07 Kanesaka; Nozomu Expandable stent
US5807404A (en) 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5824046A (en) 1996-09-27 1998-10-20 Scimed Life Systems, Inc. Covered stent
US5772669A (en) 1996-09-27 1998-06-30 Scimed Life Systems, Inc. Stent deployment catheter with retractable sheath
US5824045A (en) 1996-10-21 1998-10-20 Inflow Dynamics Inc. Vascular and endoluminal stents
US6206911B1 (en) 1996-12-19 2001-03-27 Simcha Milo Stent combination
US5868782A (en) 1996-12-24 1999-02-09 Global Therapeutics, Inc. Radially expandable axially non-contracting surgical stent
US5925061A (en) 1997-01-13 1999-07-20 Gore Enterprise Holdings, Inc. Low profile vascular stent
US5961545A (en) 1997-01-17 1999-10-05 Meadox Medicals, Inc. EPTFE graft-stent composite device
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
DE29702671U1 (en) 1997-02-17 1997-04-10 Jomed Implantate Gmbh Stent
ATE287679T1 (en) 1997-03-05 2005-02-15 Boston Scient Ltd COMPLIANT MULTI-LAYER STENT DEVICE
US5911732A (en) 1997-03-10 1999-06-15 Johnson & Johnson Interventional Systems, Co. Articulated expandable intraluminal stent
US5810872A (en) 1997-03-14 1998-09-22 Kanesaka; Nozomu Flexible stent
US5897588A (en) 1997-03-14 1999-04-27 Hull; Cheryl C. Coronary stent and method of fabricating same
US5902475A (en) 1997-04-08 1999-05-11 Interventional Technologies, Inc. Method for manufacturing a stent
US6033433A (en) 1997-04-25 2000-03-07 Scimed Life Systems, Inc. Stent configurations including spirals
US6451049B2 (en) 1998-04-29 2002-09-17 Sorin Biomedica Cardio, S.P.A. Stents for angioplasty
DE29708689U1 (en) 1997-05-15 1997-07-17 Jomed Implantate Gmbh Coronary stent
DE29708879U1 (en) 1997-05-20 1997-07-31 Jomed Implantate Gmbh Coronary stent
US5836966A (en) 1997-05-22 1998-11-17 Scimed Life Systems, Inc. Variable expansion force stent
US5913895A (en) 1997-06-02 1999-06-22 Isostent, Inc. Intravascular stent with enhanced rigidity strut members
EP0884029B1 (en) 1997-06-13 2004-12-22 Gary J. Becker Expandable intraluminal endoprosthesis
EP0890346A1 (en) 1997-06-13 1999-01-13 Gary J. Becker Expandable intraluminal endoprosthesis
FR2764794B1 (en) 1997-06-20 1999-11-12 Nycomed Lab Sa EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS
US5855600A (en) 1997-08-01 1999-01-05 Inflow Dynamics Inc. Flexible implantable stent with composite design
US5824059A (en) 1997-08-05 1998-10-20 Wijay; Bandula Flexible stent
ES2290995T3 (en) 1997-09-24 2008-02-16 Med Institute, Inc. RADIALLY EXPANDABLE ENDOPROTESIS.
US5948016A (en) 1997-09-25 1999-09-07 Jang; G. David Intravascular stent with non-parallel slots
US6013091A (en) 1997-10-09 2000-01-11 Scimed Life Systems, Inc. Stent configurations
US5964798A (en) 1997-12-16 1999-10-12 Cardiovasc, Inc. Stent having high radial strength
US6342067B1 (en) 1998-01-09 2002-01-29 Nitinol Development Corporation Intravascular stent having curved bridges for connecting adjacent hoops
US6190406B1 (en) * 1998-01-09 2001-02-20 Nitinal Development Corporation Intravascular stent having tapered struts
US6129755A (en) 1998-01-09 2000-10-10 Nitinol Development Corporation Intravascular stent having an improved strut configuration
US6179867B1 (en) 1998-01-16 2001-01-30 Advanced Cardiovascular Systems, Inc. Flexible stent and method of use
WO1999038458A1 (en) 1998-02-03 1999-08-05 Cardiovascular Interventional Systems, Inc. Tubular stent consists of non-parallel expansion struts and contralaterally attached diagonal connectors
US6113627A (en) 1998-02-03 2000-09-05 Jang; G. David Tubular stent consists of horizontal expansion struts and contralaterally attached diagonal-connectors
WO1999040876A2 (en) 1998-02-17 1999-08-19 Jang G David Tubular stent consists of chevron-shape expansion struts and ipsilaterally attached m-frame connectors
US6488701B1 (en) 1998-03-31 2002-12-03 Medtronic Ave, Inc. Stent-graft assembly with thin-walled graft component and method of manufacture
EP0938879A3 (en) 1998-02-25 2000-11-08 Medtronic Ave, Inc. Stent-graft assembly and method of manufacture
US5938697A (en) 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US5935162A (en) 1998-03-16 1999-08-10 Medtronic, Inc. Wire-tubular hybrid stent
US6132461A (en) 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent with dual support structure
US6132460A (en) 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent
US6558415B2 (en) 1998-03-27 2003-05-06 Intratherapeutics, Inc. Stent
WO1999056663A2 (en) 1998-05-05 1999-11-11 Scimed Life Systems, Inc. Stent with smooth ends
US6361759B1 (en) 1998-05-26 2002-03-26 Wisconsin Alumni Research Foundation MR signal-emitting coatings
US6261319B1 (en) 1998-07-08 2001-07-17 Scimed Life Systems, Inc. Stent
US5911754A (en) 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6461380B1 (en) 1998-07-28 2002-10-08 Advanced Cardiovascular Systems, Inc. Stent configuration
US6120522A (en) 1998-08-27 2000-09-19 Scimed Life Systems, Inc. Self-expanding stent delivery catheter
DE19839646A1 (en) 1998-08-31 2000-03-09 Jomed Implantate Gmbh Stent
DE19840645A1 (en) 1998-09-05 2000-03-09 Jomed Implantate Gmbh Stent
US6193744B1 (en) 1998-09-10 2001-02-27 Scimed Life Systems, Inc. Stent configurations
US6547814B2 (en) 1998-09-30 2003-04-15 Impra, Inc. Selective adherence of stent-graft coverings
US6042597A (en) 1998-10-23 2000-03-28 Scimed Life Systems, Inc. Helical stent design
US6190403B1 (en) 1998-11-13 2001-02-20 Cordis Corporation Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity
US6083259A (en) 1998-11-16 2000-07-04 Frantzen; John J. Axially non-contracting flexible radially expandable stent
ATE376401T1 (en) * 1998-11-20 2007-11-15 Boston Scient Ltd LONGITUDONLY FLEXIBLE AND EXPANDABLE STENT
US6503270B1 (en) 1998-12-03 2003-01-07 Medinol Ltd. Serpentine coiled ladder stent
US6355059B1 (en) 1998-12-03 2002-03-12 Medinol, Ltd. Serpentine coiled ladder stent
US6187034B1 (en) 1999-01-13 2001-02-13 John J. Frantzen Segmented stent for flexible stent delivery system
US6398803B1 (en) 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6558414B2 (en) 1999-02-02 2003-05-06 Impra, Inc. Partial encapsulation of stents using strips and bands
SE515564C2 (en) 1999-02-09 2001-08-27 Scania Cv Ab Device for locking a bonnet at a vehicle cab
US6248122B1 (en) 1999-02-26 2001-06-19 Vascular Architects, Inc. Catheter with controlled release endoluminal prosthesis
WO2000049973A2 (en) 1999-02-26 2000-08-31 Vascular Architects, Inc. Coiled stent and catheter assembly
US6273910B1 (en) 1999-03-11 2001-08-14 Advanced Cardiovascular Systems, Inc. Stent with varying strut geometry
US6364903B2 (en) 1999-03-19 2002-04-02 Meadox Medicals, Inc. Polymer coated stent
US6312457B1 (en) 1999-04-01 2001-11-06 Boston Scientific Corporation Intraluminal lining
US6730116B1 (en) 1999-04-16 2004-05-04 Medtronic, Inc. Medical device for intraluminal endovascular stenting
US6273911B1 (en) 1999-04-22 2001-08-14 Advanced Cardiovascular Systems, Inc. Variable strength stent
US6569193B1 (en) 1999-07-22 2003-05-27 Advanced Cardiovascular Systems, Inc. Tapered self-expanding stent
US6540774B1 (en) 1999-08-31 2003-04-01 Advanced Cardiovascular Systems, Inc. Stent design with end rings having enhanced strength and radiopacity
SE515231C2 (en) 1999-10-13 2001-07-02 Jan Otto Solem Covered stent and way to manufacture the same
US6331189B1 (en) 1999-10-18 2001-12-18 Medtronic, Inc. Flexible medical stent
US6409753B1 (en) 1999-10-26 2002-06-25 Scimed Life Systems, Inc. Flexible stent
US6475235B1 (en) 1999-11-16 2002-11-05 Iowa-India Investments Company, Limited Encapsulated stent preform
US6355063B1 (en) 2000-01-20 2002-03-12 Impra, Inc. Expanded PTFE drug delivery graft
US6423090B1 (en) 2000-02-11 2002-07-23 Advanced Cardiovascular Systems, Inc. Stent pattern with staged expansion
US6379382B1 (en) 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
JP3654627B2 (en) 2000-04-20 2005-06-02 川澄化学工業株式会社 Stent
US6520984B1 (en) 2000-04-28 2003-02-18 Cardiovasc, Inc. Stent graft assembly and method
US8070792B2 (en) * 2000-09-22 2011-12-06 Boston Scientific Scimed, Inc. Stent
US20020116049A1 (en) * 2000-09-22 2002-08-22 Scimed Life Systems, Inc. Stent
EP1702588B1 (en) 2000-09-22 2010-01-27 Boston Scientific Scimed, Inc. Intravascular stent apparatus
US6485508B1 (en) 2000-10-13 2002-11-26 Mcguinness Colm P. Low profile stent
US6506211B1 (en) 2000-11-13 2003-01-14 Scimed Life Systems, Inc. Stent designs
US20030033007A1 (en) 2000-12-22 2003-02-13 Avantec Vascular Corporation Methods and devices for delivery of therapeutic capable agents with variable release profile
US20010044650A1 (en) 2001-01-12 2001-11-22 Simso Eric J. Stent for in-stent restenosis
DE60209583T2 (en) 2001-03-30 2006-12-21 Terumo K.K. stent
US8197535B2 (en) 2001-06-19 2012-06-12 Cordis Corporation Low profile improved radiopacity intraluminal medical device
US6605110B2 (en) 2001-06-29 2003-08-12 Advanced Cardiovascular Systems, Inc. Stent with enhanced bendability and flexibility
JP3605388B2 (en) 2001-10-16 2004-12-22 川澄化学工業株式会社 Stent
US7354450B2 (en) 2002-01-30 2008-04-08 Boston Scientific Scimed, Inc. Stent with wishbone connectors and serpentine bands
DE10207161B4 (en) 2002-02-20 2004-12-30 Universität Hannover Process for the production of implants
EP2529707B1 (en) 2002-05-08 2015-04-15 Abbott Laboratories Endoprosthesis having foot extensions
US20030225448A1 (en) * 2002-05-28 2003-12-04 Scimed Life Systems, Inc. Polar radiopaque marker for stent
US7025777B2 (en) 2002-07-31 2006-04-11 Unison Therapeutics, Inc. Flexible and conformable stent and method of forming same
US7179286B2 (en) 2003-02-21 2007-02-20 Boston Scientific Scimed, Inc. Stent with stepped connectors
US7264633B2 (en) * 2003-03-20 2007-09-04 Cordis Corp. Anvil bridge stent design
US7112216B2 (en) * 2003-05-28 2006-09-26 Boston Scientific Scimed, Inc. Stent with tapered flexibility
US7131993B2 (en) 2003-06-25 2006-11-07 Boston Scientific Scimed, Inc. Varying circumferential spanned connectors in a stent
US7713296B2 (en) * 2003-10-16 2010-05-11 Minavasys, Sa Catheter system for stenting bifurcated vessels
US7763011B2 (en) * 2003-12-22 2010-07-27 Boston Scientific Scimed, Inc. Variable density braid stent
US8007528B2 (en) 2004-03-17 2011-08-30 Boston Scientific Scimed, Inc. Bifurcated stent
DE102004043232A1 (en) 2004-09-07 2006-03-09 Biotronik Vi Patent Ag Endoprosthesis made of magnesium alloy
US7404823B2 (en) 2005-10-31 2008-07-29 Boston Scientific Scimed, Inc. Stent configurations
US20070112418A1 (en) 2005-11-14 2007-05-17 Boston Scientific Scimed, Inc. Stent with spiral side-branch support designs

Also Published As

Publication number Publication date
US7988720B2 (en) 2011-08-02
US20080065195A1 (en) 2008-03-13
JP2010534088A (en) 2010-11-04
CN101969890A (en) 2011-02-09
US20110276126A1 (en) 2011-11-10
CA2693066C (en) 2015-04-28
WO2009014888A1 (en) 2009-01-29
EP2173284A1 (en) 2010-04-14

Similar Documents

Publication Publication Date Title
EP2059199B1 (en) Longitudinally flexible expandable stent
CA2693066C (en) Longitudinally flexible expandable stent
US7404823B2 (en) Stent configurations
US8211163B2 (en) Hybrid symmetrical stent designs
US8414637B2 (en) Stent
US20150265437A1 (en) Reduced granulation and inflammation stent design
EP2086475B1 (en) Bifurcated stent
WO2007078337A2 (en) Bifurcation stent pattern
US20070225798A1 (en) Side branch stent
US20070208411A1 (en) Bifurcated stent with surface area gradient
EP2658484A1 (en) Multi stage opening stent designs
US7951191B2 (en) Bifurcated stent with entire circumferential petal

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130425

MKLA Lapsed

Effective date: 20180709